News

Advance notice of subsidy round FMS knowledge gaps in the field of treatment COVID-19 (in Dutch)

Advance notice of subsidy round FMS knowledge gaps in the field of treatment COVID-19 (in Dutch)
Covid-19, Ecosystems, Funding
Member News, Funding news

At the beginning of March 2021, ZonMw will publish the new subsidy call for treatment at COVID-19. The purpose of this call is to answer knowledge gaps identified in the Knowledge Agenda COVID19 of the Federation of Medical Specialists (FMS) that relate to treatments. 

COVID-19 knowledge gaps relevant to this call are:

  1. What is the frequency and what are the consequences of myocardial damage with COVID-19 and which interventions can we use to prevent short and long term myocardial damage?
  2. What is a good algorithm for safely removing someone from isolation after COVID-19?
  3. Does chest CT or PET / CT add value to clinical parameters for selection (and timing) of the most effective therapy for COVID-19, and to what extent is it predictive of chronic lung damage?
  4. What is the association of frailty and biological aging processes with disease course, mortality and functional outcomes in the prevention and treatment of COVID-19 in the elderly?
  5. Is the Clinical Frailty Scale (CFS) also predictive of outcomes for patients aged 70 and older living at home with a COVID-19 infection?
  6. What is the natural course of anosmia (lack of sense of smell) in the context of COVID-19 and can this be favorably influenced with (local) corticosteroids?

COVID-19 program specific relevance criteria:

  • The research provides the urgently needed knowledge to answer the knowledge gap described in the COVID-19 Knowledge Agenda.
  • The research is of great importance because it could impact the treatment of COVID-19 patients during the pandemic and its aftermath; or contribute to better preparedness for a possible next pandemic.
  • The application must convincingly substantiate that research leads to implementable (interim) results in the short term (at least during the pandemic and also for the long term)
  • The Netherlands is in a unique position to do this, whether it concerns research in which we can add value from the Netherlands to that which has already been deployed internationally;
  • The research does not already take place elsewhere;
  • A competent research group is available to tackle this in the short term (feasibility), unless there are compelling reasons such as obtaining an METC statement. 

NEWS​

Related News

Fundación DKV Integralia: Focused on promoting inclusion in Latin America

5 Sep 2024
Learn more about the newest member to join our global community: Fundación DKV Integralia

Accelerating the diagnosis, management and support of people diagnosed with cancer in Wales and Northern Ireland

5 Sep 2024
This exciting first of its kind Cancer Challenge is a collaboration between the SBRI Centre of Excellence in Wales and the Innovation and Market Devel...

EIT Health – Flagships

5 Sep 2024
Read more and apply for the Flagships offered by EIT Health.

Digital Health Transformation in Health Institutions

5 Sep 2024
A Healthcare Transformation Academy Course

Call for Applications: 4th Cluster Booster Academy

5 Sep 2024
Managing a cluster requires a large range of skills to ensure efficient support to all cluster members and  especially to SMEs. This is why the “Clust...

xBUILD-EU 2nd call for proposals for Innovate, Global and Digital and Green grants

5 Sep 2024
Learn more and apply - xBUILD-EU 2nd call for proposals for Innovate, Global and Digital and Green grants

Become a member

Join ECHAlliance to amplify your organisation’s message, grow your networks, connect with innovators and collaborate globally.
 
First name *
Last Name *
Email Address *
Country *
Position *
First name *
Last Name *
Email Address *
Country *
Position *